GlaxoSmithKline joins POPAI Australia & New Zealand

POPAI Australia & New Zealand are proud to welcome their newest Member - GlaxoSmithKline.

GlaxoSmithKline (GSK)’s vision is to help Australians do more, feel better and live longer. Their two operating groups – GSK Pharmaceuticals and GSK Consumer Healthcare – strive each day to achieve this vision through their medicines and vaccines, significant exports, research and development, and community activities. 

They invest more than $35 million a year in Australian R&D, and contribute to export revenue through pharmaceutical and consumer healthcare exports. They supply more than 25 per cent of the world's medicinal opiate needs. Their vaccines help protect Australians from illness, and literally millions of Australians use their consumer healthcare products, such as Macleans and Panadol.

Which is why they can say, with confidence and considerable pride, that they helped someone today.

For more information, see their website at http://www.gsk.com or see the Member Directory under 'G’.